Published in Law and Health Weekly, January 20th, 2007
The objectives of the Institutional Review Board-approved study were to estimate potential enrolment rates using patient inclusion and exclusion criteria resembling those to be employed in the phase III CRO-HIV trial; to assess patient compliance by completing a daily diarrhea symptom diary; and to assess the ability of patients to abstain from medications prohibited by the protocol, including concomitant anti-diarrhea medications. Fifty-five...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.